Literature DB >> 27298422

Androgen Deprivation Therapy and Risk of Alzheimer's Disease: Importance of Holistic Geriatric Oncology Assessment.

Claire Brady1, Kieran O'Connor2, Derek G Power3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27298422      PMCID： PMC5019763          DOI： 10.1200/JCO.2016.67.8169

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  6 in total

1.  Bioavailable testosterone predicts a lower risk of Alzheimer's disease in older men.

Authors:  Leung-Wing Chu; Sidney Tam; Rachel L C Wong; Ping-Yiu Yik; Youqiang Song; Bernard M Y Cheung; John E Morley; Karen S L Lam
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

2.  Diabetes and cardiovascular disease during androgen deprivation therapy: observational study of veterans with prostate cancer.

Authors:  Nancy L Keating; A James O'Malley; Stephen J Freedland; Matthew R Smith
Journal:  J Natl Cancer Inst       Date:  2009-12-07       Impact factor: 13.506

3.  How common are the "common" neurologic disorders?

Authors:  D Hirtz; D J Thurman; K Gwinn-Hardy; M Mohamed; A R Chaudhuri; R Zalutsky
Journal:  Neurology       Date:  2007-01-30       Impact factor: 9.910

Review 4.  Sex differences in cognitive impairment and Alzheimer's disease.

Authors:  Rena Li; Meharvan Singh
Journal:  Front Neuroendocrinol       Date:  2014-01-13       Impact factor: 8.606

5.  Androgen Deprivation Therapy and Future Alzheimer's Disease Risk.

Authors:  Kevin T Nead; Greg Gaskin; Cariad Chester; Samuel Swisher-McClure; Joel T Dudley; Nicholas J Leeper; Nigam H Shah
Journal:  J Clin Oncol       Date:  2015-12-07       Impact factor: 44.544

Review 6.  Optimal management of elderly cancer patients: usefulness of the Comprehensive Geriatric Assessment.

Authors:  Philippe Caillet; Marie Laurent; Sylvie Bastuji-Garin; Evelyne Liuu; Stephane Culine; Jean-Leon Lagrange; Florence Canoui-Poitrine; Elena Paillaud
Journal:  Clin Interv Aging       Date:  2014-09-29       Impact factor: 4.458
  6 in total
  1 in total

1.  Reply to R.L. Bowen et al, M. Froehner et al, J.L. Leow et al, and C. Brady et al.

Authors:  Kevin T Nead; Greg Gaskin; Cariad Chester; Samuel Swisher-McClure; Joel T Dudley; Nicholas J Leeper; Nigam H Shah
Journal:  J Clin Oncol       Date:  2016-06-13       Impact factor: 44.544
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.